SCHEMBL7811176

SCHEMBL7811176

CCCCCCOc1nsnc1C1CN2CCC1CC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.67
CHRM2 P08172 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818970 0.99 CHRM1 (0.67) CHRM1CHRM2
SCHEMBL5932047 0.95 CHRM1 (0.66) CHRM1CHRM2
Oxalic Acid SCHEMBL7818943 0.92 CHRM1 (0.59) CHRM1CHRM2
Fumaric Acid SCHEMBL7825740 0.91 CHRM1 (0.57) CHRM1CHRM2
Fumaric Acid SCHEMBL7825743 0.91 CHRM1 (0.57) CHRM1CHRM2
SCHEMBL7810892 0.90 CHRM1 (0.57) CHRM1CHRM2
Oxalic Acid SCHEMBL7819803 0.89 CHRM1 (0.58) CHRM1CHRM2
SCHEMBL7823175 0.87 CHRM2 (0.58) CHRM1CHRM2
SCHEMBL9057188 0.86 CHRM1 (0.54) CHRM1CHRM2
SCHEMBL7810995 0.86 CHRM2 (0.59) CHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281233-B1 AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES NOVO NORDISK A/S (DK) 2001-08-28 US claimed
EP-0714394-B1 ANTIPSYCHOTIC METHOD WITH THIADIAZOLE AND OXADIAZOLE DERIVATIVES NOVO NORDISK AS (DK) 2001-06-20 EP claimed
EP-0544779-B1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1998-12-02 EP claimed
EP-0873124-A1 A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS NOVO NORDISK A/S (DK) 1998-10-28 EP claimed
WO-1997025043-A1 A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS NOVO NORDISK A/S (DK) 1997-07-17 WO claimed
EP-0735869-A1 A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS NOVO NORDISK A/S (DK) 1996-10-09 EP claimed
WO-1996014316-A1 A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS NOVO NORDISK A/S (DK) 1996-05-17 WO claimed
WO-1995017180-A1 A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS NOVO NORDISK A/S (DK) 1995-06-29 WO claimed
EP-0709093-B1 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound LILLY CO ELI (US) 2000-04-05 EP disclosed
EP-0873124-A1 A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS NOVO NORDISK A/S (DK) 1998-10-28 EP disclosed
WO-1997025043-A1 A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS NOVO NORDISK A/S (DK) 1997-07-17 WO disclosed
WO-1996013166-A1 METHOD FOR TREATING ANXIETY ELI LILLY AND COMPANY (US) 1996-05-09 WO disclosed
EP-0709093-A2 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound ELI LILLY AND COMPANY (US) 1996-05-01 EP disclosed
US-5484794-A THIA- OR OXA-DIAZOLE COMPOUNDS ELI LILLY AND COMPANY (US) 1996-01-16 US disclosed